This page lists the SEC filings reported by Global Life Bioventure IV S.a.r.l..
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2018-02-05 | Global Life Bioventure IV S.a.r.l. | Nabriva Therapeutics plc | 0 | 0.0% | EDGAR |
SC 13G/A | 2017-02-14 | Global Life Bioventure IV S.a.r.l. | PIERIS PHARMACEUTICALS, INC. | 1,697,384 | 3.9% | EDGAR |
SC 13G | 2015-09-29 | Global Life Bioventure IV S.a.r.l. | Nabriva Therapeutics AG | 114,589 | 5.8% | EDGAR |
SC 13G | 2015-09-11 | Global Life Bioventure IV S.a.r.l. | PIERIS PHARMACEUTICALS, INC. | 2,483,949 | 6.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.